Biodesix, Inc. (Biodesix)

Oncology Corporate Profile

HQ Location

520 Zang Street, Suite 213
Broomfield, CO 80021

Company Description

Biodesix is a personalized medicine company focused on the development of diagnostic products that inform treatment decisions and improve patient care. The Company’s goal is to give physicians more information about the patient and their disease; understanding the clinically meaningful information contained within each patient’s molecular profile leads to better care and better outcomes. The Company’s unique approach is based on ProTS®, proprietary technology which exploits the power of mass spectrometry and enables the discovery of specific molecular profiles. Biodesix collaborates with clinical investigators to address critical clinical questions, and partners with biotechnology and pharmaceutical companies to develop diagnostics to select patients most likely to benefit from novel therapies.


Brand Generic Indication
VeriStrat??serum proteomic testVeriStrat is intended for 2nd and 3rd line advanced non-small cell lung cancer(NSCLC) patients who are eligible for EGFR-TKI therapy.

View additional information on commercial products here »

  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
VeriStratt_ serum proteomic testColorectal cancerDevelopment
VeriStrat_ serum proteomic testSquamous cell carcinoma of the Head & NeckDevelopment

View additional information on product candidates here »


Recent News Headlines

There are no news items to display